Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Engy A. Mogahed"'
Autor:
Clinical Adaptation Group (GAG), Bahia Moustafa, Neveen A. Soliman, Ahmed Badr, Mohamad K. EL-Hatw, Engy A. Mogahed, Mona El Ghamrawy, Noha Shaheen, Khaled M. ElKhashab, Mohamed G. Shouman, Abeer Selim, Sawsan Moselhy, Dina E. Sallam, Magdy El-Sharkawy, Tarek A. AbdelAzim, Mohamad Esmat, Nanies Soliman, Mostafa Baraka, Bedeir Ali-El-Dein, Muhammed Ahmed Elhadedy, Moatasem Elsayed Ghoneim, Mai S. Korkor, Methodology Guideline Adaptation Group (GAG), Tarek Omar, Yasser S. Amer, Ashraf Abdel Baky, on Behalf of Egyptian Pediatric Clinical Practice Guidelines Committee (EPG)
Publikováno v:
Egyptian Pediatric Association Gazette, Vol 72, Iss 1, Pp 1-18 (2024)
Abstract Background Kidney transplantation for chronic kidney disease (CKD) in children is the best treatment option. It needs special medical and surgical expertise highly skilled in management of pediatric age group. Our Egyptian profile for causes
Externí odkaz:
https://doaj.org/article/77c8307ab8554d0c983e0b8dec05cbe2
Autor:
Abeer Awad Abdellatif, Mohamad Sherif Mogawer, Mostafa El- Shazli, Hanaa El-Karaksy, Ayman Salah, Amany Abdel-Maqsod, Mona El-Amir, Mohamed Said, Naglaa Zayed, Karim Hosny, Hadeel Gamal Eldeen, Ayman M. A. Osman, Doaa A. Mansour, Ahmed Nabil, Ahmed Abdel-Ghani, Engy A. Mogahed, Noha A. Yasin
Publikováno v:
Egyptian Liver Journal, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Background Solid organ transplantation (SOT) service has been disrupted during the current coronavirus disease 2019 (COVID-19) pandemic, which deferred the service in most centers worldwide. As the pandemic persists, there will be an urgency
Externí odkaz:
https://doaj.org/article/da1eb6f7891842029ad24749ecfea896
Autor:
Engy Adel Mogahed, Hend M. Soliman, Dalia Saber Morgan, Hoda Mohammed Abd Elaal, Rasha Abd El Razek Mahmoud Khattab, Ragaey A Eid, Mahmoud Hodeib
Background Autoimmune hepatitis (AIH) is an organ specific autoimmune disease, which can manifest at any age of life. there is a high prevalence of extrahepatic autoimmune diseases in patients with AIH. Autoimmune thyroid diseases (ATDs) are the most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02a9e4e2b0ff5193d0ff27b74352e3b5
https://doi.org/10.21203/rs.3.rs-2762498/v1
https://doi.org/10.21203/rs.3.rs-2762498/v1
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0203808 (2018)
Ascitic fluid infection is a major cause of morbidity and mortality in cirrhotic patients, requiring early diagnosis and therapy. We aimed to determine predictors of ascitic fluid infection in children with chronic liver disease. The study included 4
Externí odkaz:
https://doaj.org/article/a5291b36a38c430d82e29cd23db2a6f2
Autor:
Noha A.E. Yasin, Shereen Abdel Alem, Engy A. Mogahed, Hadeel Gamal Eldeen, Ahmed Nagy, Hala Abdullatif, Hanaa M. El-Karaksy, Mona S. El-Raziky
Publikováno v:
The Journal of Pediatrics. 233:126-131
To assess the degree of liver stiffness using transient elastography in Egyptian children infected with hepatitis C virus (HCV) at baseline and 1 year after achievement of sustained virologic response (SVR) with direct acting antivirals.This prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d3275f62e39c1a682cc163692977a1
https://doi.org/10.1016/j.jpeds.2021.02.012
https://doi.org/10.1016/j.jpeds.2021.02.012
Publikováno v:
European Journal of Pediatrics. 179:719-726
This study aimed to detect etiologies and histopathological features of non-alcoholic fatty liver disease (NAFLD) in Egyptian children 10 years from hepatologist perspectives. Infants and children below 10 years of age with biopsy-proven fatty liver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d4ce8faea2baaabbba0a34d5e8a0b9
https://doi.org/10.1007/s00431-019-03551-0
https://doi.org/10.1007/s00431-019-03551-0
Autor:
Mariam El-Moslemany, Mona S. El-Raziky, M. Abo-Elsoud, Noha Musa, Engy A. Mogahed, Ihab Aboueleyoun
Publikováno v:
Archives of Medical Science.
IntroductionGlycogen storage disease III (GSD III) is an inborn error of carbohydrate metabolism that involves mainly the liver and skeletal muscles with rare potential systemic complications as osteoporosis. The aim of work of the current study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97a3d20254b75c5025c639496d1017d7
https://doi.org/10.5114/aoms/141986
https://doi.org/10.5114/aoms/141986
Autor:
Hala Abdullatif, Rania Ramzi, Basma Abd El Rasheed Abd El Zaher, Carolyne Ghobrial, Hanaa El-Karaksy, Mona S. El Raziky, Engy A. Mogahed
Publikováno v:
Clinical Drug Investigation. 39:857-864
Drug–drug interactions need to be considered to optimize the pharmacotherapeutic outcome of direct-acting antivirals. The aim of this study was to report on possible drug–drug interactions between ledipasvir/sofosbuvir and other medications recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d96d15fbe419e72fa5ac7d3fa2eb6e0
https://doi.org/10.1007/s40261-019-00805-5
https://doi.org/10.1007/s40261-019-00805-5
Publikováno v:
Archives of Medical Science : AMS
Infection with hepatitis C virus (HCV) is a major health problem worldwide. A large proportion of perinatal HCV infections are silent and may present later in adulthood with long-term complications. HCV has no effective immune prophylaxis and hence a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862337e4904b4d33fa97bbf26a7951cc
http://europepmc.org/articles/PMC7667440
http://europepmc.org/articles/PMC7667440
Publikováno v:
Digestive and Liver Disease. 51:258-262
Background Symptomatic bradycardia has been reported in adults treated for chronic hepatitis C using sofosbuvir based regimens. Aim We studied the cardiac safety of sofosbuvir/ledipasvir in Egyptian children, treated for chronic hepatitis C. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b77f1c5e922729f6eb2ec766ab64235
https://doi.org/10.1016/j.dld.2018.09.012
https://doi.org/10.1016/j.dld.2018.09.012